Systemic Targeted Adaptive RadioTherapy of NeuroEndocrine Tumors.

Clinical trial NCT05387603 · RECRUITING

Trial details

NCT number: NCT05387603
Sponsor: Lund University Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Neuroendocrine Tumors

Start date: 2022-11-01
Primary completion: 2026-10-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.